Crux Biolabs
Kate Porter has extensive experience in the field of pre-clinical and clinical research and development, with a focus on immunology, small-molecule oncology, antiviral, and antibacterial spaces. Kate has held various leadership positions in reputable organizations such as Crux Biolabs, Noxopharm, and BIOTA. Kate's educational background includes a PhD in Microbiology and a Bachelor of Biomedical Science. Additionally, Kate has experience in mentoring and facilitating science education programs.
This person is not in any teams
Crux Biolabs
Crux Biolabs is an Australian bioanalytical laboratory specialising in PBMC processing, pharmacodynamics (biomarker, flow cytometry, ELISpot and ADA) and pharmacokinetics (large and small molecule) for clinical research. Our expert scientists can customise and validate a wide range of biomarker and cell assays in our ISO 17025 accredited lab in Melbourne, Australia. We also offer PBMC processing in Sydney with our dedicated satellite laboratory. We understand that each study is unique. That’s why we take pride in becoming an extension of your team to deliver the best outcome for your studies. Crux Biolabs - where science leads.